New York State Common Retirement Fund
ACOR

New York State Common Retirement Fund’s Acorda Therapeutics ACOR Stock Holding History

New York State Common Retirement Fund’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-357
Closed -$40K – 3310
2020
Q1 		$40K Hold
357
– – ﹤0.01% 3026
2019
Q4 		$87K Hold
357
– – ﹤0.01% 3036
2019
Q3 		$123K Hold
357
– – ﹤0.01% 2974
2019
Q2 		$328K Sell
357
-201
-36% -$247K ﹤0.01% 2576
2019
Q1 		$891K Sell
558
-35
-6% -$63.1K ﹤0.01% 2024
2018
Q4 		$1.11M Buy
593
+139
+31% +$302K ﹤0.01% 1859
2018
Q3 		$1.07M Hold
454
– – ﹤0.01% 2052
2018
Q2 		$1.56M Buy
454
+62
+16% +$190K ﹤0.01% 1845
2018
Q1 		$1.11M Hold
392
– – ﹤0.01% 1966
2017
Q4 		$1.01M Hold
392
– – ﹤0.01% 2031
2017
Q3 		$1.11M Hold
392
– – ﹤0.01% 1951
2017
Q2 		$926K Hold
392
– – ﹤0.01% 2087
2017
Q1 		$987K Hold
392
– – ﹤0.01% 2039
2016
Q4 		$884K Hold
392
– – ﹤0.01% 2109
2016
Q3 		$981K Buy
392
+34
+9% +$101K ﹤0.01% 2001
2016
Q2 		$1.1M Sell
358
-896
-71% -$2.91M ﹤0.01% 1933
2016
Q1 		$3.98M Buy
1,254
+10
+0.8% +$41.5K 0.01% 1301
2015
Q4 		$6.38M Buy
1,244
+13
+1% +$56.8K 0.01% 1120
2015
Q3 		$3.92M Sell
1,231
-493
-29% -$1.91M 0.01% 1310
2015
Q2 		$6.9M Sell
1,724
-60
-3% -$232K 0.01% 1167
2015
Q1 		$7.12M Hold
1,784
– – 0.01% 1028
2014
Q4 		$8.75M Sell
1,784
-200
-10% -$858K 0.01% 933
2014
Q3 		$8.06M Buy
1,984
+43
+2% +$161K 0.01% 986
2014
Q2 		$7.85M Buy
1,941
+390
+25% +$1.59M 0.01% 1049
2014
Q1 		$7.05M Buy
1,551
+739
+91% +$2.99M 0.01% 1072
2013
Q4 		$2.85M Buy
812
+7
+0.9% +$27.3K ﹤0.01% 1475
2013
Q3 		$3.31M Buy
805
+24
+3% +$103K 0.01% 1346
2013
Q2 		$3.09M Buy
+781
New +$3.22M 0.01% 1269

Other funds holding ACOR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

New York State Common Retirement Fund's ACOR Position: Q2 2020 in Review

New York State Common Retirement Fund sold out of Acorda Therapeutics (ACOR) in Q2 2020, closing a stake of 357 shares — an estimated $40K sold.

New York State Common Retirement Fund first reported a position in ACOR in Q2 2013 and held it in 28 quarters. The position peaked at $8.75M in Q4 2014. 79 funds tracked by Wall St. Rank hold ACOR as of Q2 2020.

  • New York State Common Retirement Fund reported no remaining Acorda Therapeutics position as of Q2 2020 after selling out during the quarter.
  • New York State Common Retirement Fund sold 357 Acorda Therapeutics shares in Q2 2020, an estimated $40K.
  • New York State Common Retirement Fund first reported a position in Acorda Therapeutics in Q2 2013 and held it in 28 quarters.
  • New York State Common Retirement Fund's Acorda Therapeutics position peaked at $8.75M in Q4 2014.
  • 79 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2020.

Based on New York State Common Retirement Fund's 13F filing for Q2 2020, filed 7 Aug 2020.